세계의 원내감염 대책 시장 : 종류별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Hospital Acquired Infection Control Market size was valued at USD 21,345.98 Million in 2024, expanding at a CAGR of 6.80% from 2024 to 2032.

Hospital Acquired Infection (HAI) Control refers to the comprehensive strategies and practices implemented within healthcare facilities to prevent, monitor, and manage infections that patients acquire during their stay in a hospital or clinical setting. These infections typically develop 48 hours or more after admission and are not present or incubating at the time of entry. Effective HAI control involves a combination of strict hygiene protocols, sterilization of medical instruments, appropriate use of personal protective equipment (PPE), antimicrobial stewardship, and staff training. Surveillance systems are also essential to detect outbreaks and track infection trends. Key infections targeted include bloodstream infections, urinary tract infections, pneumonia, and surgical site infections. The aim is to protect both patients and healthcare workers, minimize complications, reduce healthcare costs, and improve patient outcomes. Continuous education, adherence to guidelines such as those from the CDC or WHO, and institutional commitment are critical to ensuring successful infection control in hospitals.

Hospital Acquired Infection Control Market- Market Dynamics

Rising Awareness of Hospital-Acquired Infections (HAIs)

Increasing awareness about the risks and consequences of hospital-acquired infections is a significant driver of the HAI control market. Healthcare professionals, administrators, and patients are becoming more informed about the dangers posed by HAIs, such as prolonged hospital stays, increased healthcare costs, and higher mortality rates. This growing awareness has prompted healthcare facilities to prioritize infection control measures and invest in advanced prevention technologies. Regulatory bodies and health organizations worldwide, including the WHO and CDC, have issued stringent guidelines, further emphasizing the importance of HAI surveillance and control. In response, hospitals are adopting robust infection prevention protocols, including the use of antimicrobial surfaces, sterilization equipment, and digital tracking systems. Additionally, public health campaigns and media coverage have educated the general population, leading to greater patient expectations for safety. As a result, the demand for infection control solutions is expanding across both developed and emerging markets.

HOSPITAL ACQUIRED INFECTION CONTROL Market- Key Insights

According to our research analyst, the global Hospital Acquired Infection Control Market is expected to develop at a CAGR of approximately 6.80% between 2024-2032.

Segmented by Type in 2023, the Equipment category dominated the market.

Based on End Use segmentation, the Hospitals and Intensive Care Units (ICUs) generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Hospital Acquired Infection Control Market- Segmentation Analysis:

The global Hospital Acquired Infection Control market is divided into three categories: type, end use and region.

The Hospital Acquired Infection (HAI) Control market is segmented by type into Equipment, Services, and Consumables. Equipment includes sterilization devices, disinfection systems, and air purification units essential for maintaining a sterile healthcare environment. Services encompass infection surveillance, training, and compliance management offered by specialized providers. Consumables such as disinfectants, antiseptics, gloves, gowns, and masks are used daily to prevent the spread of infections. Equipment is set to dominate the market, driven by increasing investments in advanced disinfection technologies such as UV-C systems, automated sterilizers, and HEPA filtration. Hospitals and healthcare facilities are prioritizing durable infrastructure that ensures consistent infection prevention, especially in high-risk areas like ICUs and operating rooms. The push for long-term infection control solutions and compliance with international safety standards is accelerating the adoption of cutting-edge equipment. As healthcare systems modernize, equipment is expected to lead in market share due to its critical role in comprehensive infection control strategies.

The Hospital Acquired Infection (HAI) Control market is categorized by end-use into Hospitals and Intensive Care Units (ICUs), Ambulatory Surgical and Diagnostic Centres, and Others, which include long-term care facilities and clinics. Hospitals and ICUs are projected to dominate the market due to the high volume of patient admissions, complex medical procedures, and increased risk of infection transmission in these settings. ICUs, in particular, deal with immunocompromised patients, invasive devices, and extended hospital stays, making them hotspots for HAIs. As a result, these units require strict infection control protocols and continuous investment in equipment, consumables, and specialized services. The implementation of hospital-wide hygiene standards, government regulations, and accreditation requirements further drives demand in this segment. Moreover, the rising global burden of HAIs and the need to reduce associated healthcare costs make hospitals and ICUs the leading consumers of infection control solutions.

Hospital Acquired Infection Control Market- Geographical Insights

Geographically, the Hospital Acquired Infection Control Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Hospital Acquired Infection (HAI) Control market, driven by advanced healthcare infrastructure, stringent government regulations, and increasing awareness about infection control. The United States, with its large healthcare system and rising prevalence of healthcare-associated infections, holds the largest market share in the region. The Centers for Disease Control and Prevention (CDC) and other regulatory bodies enforce strict infection control measures, encouraging hospitals and healthcare providers to invest heavily in equipment, consumables, and services. Additionally, the high adoption rate of advanced technologies, such as automated sterilization systems and air purification units, further boosts market growth. Canada also plays a significant role, focusing on enhancing infection prevention through public health campaigns and healthcare modernization.

Europe is another dominant region in the HAI Control market, driven by a strong healthcare system and a focus on patient safety. The European Union has introduced regulations aimed at improving infection prevention and reducing the incidence of hospital-acquired infections, fostering market growth. Countries like Germany, the UK, and France have well-established healthcare infrastructures and are increasingly adopting advanced infection control technologies, such as UV sterilization and antimicrobial surface coatings. The region's emphasis on maintaining high healthcare standards, combined with rising awareness and demand for effective infection control solutions, positions Europe as a key player in the market. Additionally, the European market benefits from strong collaborations between healthcare providers and infection control solution suppliers, ensuring widespread adoption of best practices.

Hospital Acquired Infection Control Market- Competitive Landscape:

The competitive dynamics of the Hospital Acquired Infection (HAI) Control market are shaped by a mix of established players and new entrants focusing on advanced technologies. Major companies like 3M, Belimed Inc., Getinge, and STERIS dominate the market with a comprehensive range of infection control solutions, including sterilization systems, disinfectants, and personal protective equipment (PPE). These companies are known for their emphasis on product quality, regulatory compliance, and robust R&D efforts to enhance product features. They also make significant investments in digital health solutions to improve infection surveillance and tracking. Additionally, new entrants and innovators, such as W&H and Midmark Corporation, are introducing advanced sterilization equipment and automation systems to improve safety and efficiency. For instance, Sterigenics, a key player in the market, focuses on gamma sterilization technology and expanding its sterilization capabilities globally. This competitive environment fosters innovation and drives improvements in infection control protocols, benefiting healthcare providers and patient outcomes.s

Recent Developments:

In September 2023, 3M launched the Clean-Coat Surface Protectant, a coating designed to eliminate up to 99.9% of bacteria and viruses on high-touch surfaces in hospitals. This innovation aims to reduce the risk of cross-contamination in healthcare environments.

In October 2023, Getinge expanded its sterilization capabilities by acquiring Healthmark Industries Co., Inc., strengthening its position in the U.S. infection control market and enhancing its offerings for instrument sterilization and compliance.

In March 2024, W&H introduced the eLog system, a digital logbook that automatically records and saves sterilization cycles and routine tests. This system enhances workflow efficiency while ensuring compliance with sterilization documentation requirements.

In July 2024, Midmark Corporation unveiled its next-generation M11 and M9 steam sterilizers, featuring enhanced durability and integrated capabilities to streamline instrument processing and improve compliance documentation efficiency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• 3M
• Belimed Inc.
• O&M Halyards
• Getinge
• ASP (Advanced Sterilization Products Services, Inc.)
• Sterigenics U.S., LLC - A Sotera Health Company
• MMM Group
• Midmark Corporation
• STERIS
• W&H
• Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• Equipment
• Sterilization Equipment
• Heat Sterilization Equipment
• Low Temperature Sterilization
• Radiation Sterilization
• Disinfection Equipment
• Washer Disinfector
• Flusher Disinfector
• Endoscopic Reprocessor Systems
• Services
• Consumables
• Disinfectants
• Sterilization Consumables

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

• Hospitals and Intensive Care Units (ICUs)
• Ambulatory Surgical and Diagnostic Centres
• Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Hospital Acquired Infection Control Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Hospital Acquired Infection Control Market Snippet by Type
  • 2.1.2. Hospital Acquired Infection Control Market Snippet by End-Use
  • 2.1.3. Hospital Acquired Infection Control Market Snippet by Country
  • 2.1.4. Hospital Acquired Infection Control Market Snippet by Region
• 2.2. Competitive Insights

3. Hospital Acquired Infection Control Key Market Trends

• 3.1. Hospital Acquired Infection Control Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Hospital Acquired Infection Control Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Hospital Acquired Infection Control Market Opportunities
• 3.4. Hospital Acquired Infection Control Market Future Trends

4. Hospital Acquired Infection Control Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Hospital Acquired Infection Control Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Hospital Acquired Infection Control Market Landscape

• 6.1. Hospital Acquired Infection Control Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Hospital Acquired Infection Control Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
  • 7.1.2. Equipment
    • 7.1.2.1. Sterilization Equipment
    • 7.1.2.1.1. Heat Sterilization Equipment
    • 7.1.2.1.2. Low Temperature Sterilization
    • 7.1.2.1.3. Radiation Sterilization
    • 7.1.2.2. Disinfection Equipment
    • 7.1.2.2.1. Washer Disinfector
    • 7.1.2.2.2. Flusher Disinfector
    • 7.1.2.2.3. Endoscopic Reprocessor Systems
  • 7.1.3. Services
  • 7.1.4. Consumables
    • 7.1.4.1. Disinfectants
    • 7.1.4.2. Sterilization Consumables

8. Hospital Acquired Infection Control Market - By End-Use

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
  • 8.1.2. Hospitals and Intensive Care Units (ICUs)
  • 8.1.3. Ambulatory Surgical and Diagnostic Centres
  • 8.1.4. Others

9. Hospital Acquired Infection Control Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Hospital Acquired Infection Control Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Hospital Acquired Infection Control Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.7. France
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.7.4. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.8. Italy
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.8.4. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.9. Spain
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.9.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.10. United Kingdom
    • 9.3.10.1. Overview
    • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.10.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.11. Russia
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.12. Netherlands
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.13. Sweden
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.14. Poland
    • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.14.3. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3.15. Rest of Europe
    • 9.3.15.1. Overview
    • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Hospital Acquired Infection Control Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.8. South Korea
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.8.4. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.9. Japan
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.9.4. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Hospital Acquired Infection Control Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Hospital Acquired Infection Control Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hospital Acquired Infection Control Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. 3M
  • 10.2.2. Belimed Inc.
  • 10.2.3. O&M Halyards
  • 10.2.4. Getinge
  • 10.2.5. ASP (Advanced Sterilization Products Services, Inc.)
  • 10.2.6. Sterigenics U.S., LLC - A Sotera Health Company
  • 10.2.7. MMM Group
  • 10.2.8. Midmark Corporation
  • 10.2.9. STERIS
  • 10.2.10. W&H
  • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us